Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

News from the ACS: Lilly investigates antioxidants for treating neuronal injury

Aug. 28, 1998

News from the ACS: Roche synthesizes selective 5-HT2C antagonists

Aug. 28, 1998

Schwarz, Discovery Therapeutics collaborate on transdermal treatment for Parkinson's disease

Aug. 27, 1998

Pierre Fabre describes antidepressant compounds with a dual mechanism of action

Aug. 27, 1998

Algos completes full NDA filing for MorphiDex

Aug. 27, 1998

Adding SIB-1508Y to antiparkinsonian therapy allows for reduction in dose of L-dopa

Aug. 27, 1998

SSRI produces significant improvements in patients with social phobia

Aug. 26, 1998

Parke-Davis synthesizes potent and selective D4 ligands with antipsychotic potential

Aug. 26, 1998

Allelix research into antimigraine compounds proves fruitful

Aug. 26, 1998

Neuroprotective glutamate receptor antagonists disclosed by Warner-Lambert

Aug. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...